Published in
Wiley, American Journal of Hematology, 12(97), p. 1510-1519, 2022
DOI: 10.1002/ajh.26709
Links
Tools
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor‐naïve patients with myelofibrosis: Results of a phase II trial
Journal article published in 2022 by
Yi Zhang 
,
Hu Zhou,
Zhongxing Jiang,
Dengshu Wu,
Junling Zhuang ,
Wei Li,
Qian Jiang ,
Xiuli Wang,
Jinwen Huang,
Huanling Zhu ,
Linhua Yang,
Xin Du,
Fei Li,
Ruixiang Xia,
Feng Zhang
and other authors.
,
Hu Zhou,
Zhongxing Jiang,
Dengshu Wu,
Junling Zhuang ,
Wei Li,
Qian Jiang ,
Xiuli Wang,
Jinwen Huang,
Huanling Zhu ,
Linhua Yang,
Xin Du,
Fei Li,
Ruixiang Xia,
Feng Zhang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 